Can dancing ease the exhaustion of breast cancer treatment?
NCT ID NCT07817355
First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time
Summary
Researchers are testing whether a 12-week supervised dance-based exercise program can reduce cancer-related fatigue in women with newly diagnosed breast cancer who are having treatment before surgery. The study includes 104 women aged 18 to 60 who will be randomly assigned to either the dance program plus standard care or standard care alone. The dance group attends three 60-minute sessions per week that combine aerobic dance with exercises for coordination, balance, and strength. Researchers will measure fatigue, quality of life, physical fitness, and biological markers over time.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a supervised dance-based exercise program
- What this could lead to
- If it works, dance-based exercise could become a low-cost, accessible way to help women manage cancer-related fatigue during breast cancer treatment.
- What could go wrong
- This is a single study in a specific group of women, so results may not apply to everyone. Exercise during cancer treatment can be tiring or difficult, and some participants may not complete the full 12-week program.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 104 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Signed and dated written informed consent. Female patients with histologically confirmed, newly diagnosed, non-metastatic invasive breast cancer. Age 18-60 years. Body mass index (BMI) \<35 kg/m². Indication for and planned initiation of neoadjuvant treatment at the National Cancer Institute in Bratislava, Slovakia, or St. Elizabeth Cancer Institute in Bratislava, Slovakia. Planned definitive breast surgery following completion of neoadjuvant treatment. Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. Ability to understand and complete the study questionnaires and comply with study procedures. Ability and willingness to participate in the supervised dance intervention, as determined by the investigator. Medical clearance for participation in moderate-intensity physical activity. Exclusion Criteria: Metastatic breast cancer at the time of study enrollment. Recurrent breast cancer or previous treatment for the current breast cancer, except for diagnostic biopsy and other diagnostic procedures. Previous invasive malignancy within the preceding 5 years, except for adequately treated non-melanoma skin cancer, carcinoma in situ, or another malignancy considered by the investigator unlikely to interfere with study outcomes. ECOG performance status ≥2. Any uncontrolled cardiovascular, respiratory, neurological, musculoskeletal, or other medical condition that, in the investigator's judgment, would make participation in the dance intervention unsafe. Clinically significant laboratory abnormalities that, in the investigator's judgment, would make participation in the physical intervention unsafe. Pregnancy or breastfeeding. Inability or unwillingness to comply with study procedures, the intervention schedule, sample collection, or follow-up assessments. Any psychological, cognitive, social, or language-related condition that would prevent provision of valid informed consent or reliable completion of study assessments.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast neoplasms are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute
Bratislava, 83310, Slovakia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI reads tumor slides to match cancer patients with trials
- Lung imaging could reveal the best anesthetic dose for breast surgery
- Can a Dual-Target drug crack resistant gynecologic and breast cancers?
- AI turns routine chest scans into breast cancer detector
- One shot of radiation: can a single dose replace weeks of breast cancer treatment?
- Could skipping a lymph node check spare women from unneeded surgery?